Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

Samer A. Al’Hadidi, MD, discusses factors influencing early use of chimeric antigen receptor T-cell therapy in patients with ...

Many of you may remember from this column that I have multiple myeloma, or cancer of the bone marrow. In January, I will be headed to UVA hospital for a ...

Helen van Bueren, 77, from Derbyshire, who has Multiple Myeloma, is one of those who has lost her Winter Fuel Payment and ...

The global CAR-T Cell Therapy market size is expected to reach USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026 according to a new study published by Report Ocean. Request To ...

Am J Health Syst Pharm. 2007;64(17):1799-1807. Despite a similar chemical structure to thalidomide, the toxicity profile of lenalidomide has been shown to be quite different. The major dose ...

Helen van Bueren, 77, from Derbyshire, who has Multiple Myeloma, is one of those who has lost her Winter Fuel Payment. She ...

Maczko said her brother died in 2016 of multiple myeloma and she had other loved ones with cancer. "We started a team years ...

There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

Around 44,000 people with terminal illnesses will lose the payment, worth up to £300, according to figures obtained by Marie ...